4 Smallcap High Margin and Fast Revenue Growth Stocks to Watch for Future Multibagger Potential: Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Vijaya Diagnostic Rs 1,464.20. Metropolis Rs 553.85. Paras Defence Rs 1,329.70. Genus Power Rs 278.30. Market caps from Rs 8,693 crore to Rs 15,226 crore. Data as of 29 Oct 2026.
Quick Answer
Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power are the 4 picks in this high margin and fast revenue growth stocks watchlist, with market caps between Rs 8,693 crore and Rs 15,226 crore. Vijaya Diagnostic stands out for the largest market cap at Rs 15,226 crore, while Metropolis offers 24.15% revenue growth in FY26. PE ratios run from 13.34 to 113.23, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
High margin and fast revenue growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power meet that test, with market caps from Rs 8,693 crore to Rs 15,226 crore and Vijaya Diagnostic offering the largest market cap at Rs 15,226 crore. Each of these companies has a market capitalisation below Rs 30,000 crore and an operating margin of at least 20 per cent and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation below Rs 30,000 crore and an operating margin of at least 20 per cent and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap below Rs 30,000 crore. Investors screening high margin and fast revenue growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are High Margin and Fast Revenue Growth Stocks and Why Do They Attract Multibagger Interest?
High margin and fast revenue growth stocks are shares of smaller companies that keep at least twenty paise of operating profit from every rupee of sales while also growing sales by fifteen per cent or more, a rare mix of quality and speed. The four here cover pathology diagnostics, smart meters and defence electronics.
Strong margins show pricing power and cost control, and fast revenue growth shows rising demand, so a company with both is building a bigger business without giving up profitability. For high margin and fast revenue growth stocks, both FY26 and the latest quarter showed growth. Whichever way you read high margin and fast revenue growth stocks, the common thread is rising profit backed by complete financial data. For high margin and fast revenue growth stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of high margin and fast revenue growth stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for high margin and fast revenue growth stocks before you decide.
High Margin and Fast Revenue Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 29 October 2026. Genus Power combines the lowest PE of the group, 13.34, with the highest return on equity, 26.71%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre | 1,464.20 | 15,226 | 81.23 | 60.75 | 18.07% | 0.44 | 848.00 to 1,593.60 |
| Metropolis Healthcare | 553.85 | 11,603 | 57.19 | 60.75 | 12.56% | 0.15 | 453.50 to 733.00 |
| Paras Defence and Space Technologies | 1,329.70 | 10,859 | 113.23 | 48.70 | 12.14% | 0.04 | 580.50 to 1,585.00 |
| Genus Power Infrastructures | 278.30 | 8,693 | 13.34 | 45.71 | 26.71% | 1.04 | 210.40 to 363.00 |
Vijaya Diagnostic: Quarterly Profit Up 37.60%
Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.
In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 141.31% over five years and 38.44% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026. The stock trades at a PE of 81.23 against an industry PE of 60.75, with a return on equity of 18.07%.
Metropolis: Revenue Up 24.15% in FY26
Metropolis Healthcare provides pathology and diagnostic services through a network of laboratories, clinical labs and collection centres. It reported FY26 revenue of Rs 1,671.43 crore, up 24.15% year on year, and net profit of Rs 191.18 crore, up 31.39%. Revenue has compounded at 7.62% a year since FY22. Operating margin was 25.63% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.
The stock trades at a PE of 57.19 against an industry PE of 60.75, below the sector average, with a return on equity of 12.56%. In the June 2026 quarter, revenue rose 15.69% to Rs 455.32 crore and net profit grew 25.70% to Rs 56.88 crore. Domestic institutions raised their holding from 32.40% in June 2025 to 35.12% in June 2026.
Paras Defence: 34.81% Profit CAGR Since FY22
Paras Defence and Space Technologies makes defence optics, electromagnetic protection systems and space optics, and has a growing drone and anti-drone portfolio. It reported FY26 revenue of Rs 492.56 crore, up 32.20% year on year, and net profit of Rs 89.45 crore, up 45.47%. Net profit has compounded at 34.81% a year since FY22, while revenue has grown 27.65% a year. Operating margin was 29.65% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.
In the June 2026 quarter, revenue rose 35.87% to Rs 129.85 crore and net profit grew 45.34% to Rs 20.74 crore. The share price has gained 235.84% over five years and 79.10% over the past year. Domestic institutions raised their holding from 1.47% in September 2025 to 4.63% in September 2026. The stock trades at a PE of 113.23 against an industry PE of 48.70, with a return on equity of 12.14%.
Genus Power: 76.37% Profit CAGR Since FY22
Genus Power Infrastructures makes smart meters and metering solutions for power utilities. It reported FY26 revenue of Rs 4,821.22 crore, up 90.97% year on year, and net profit of Rs 564.95 crore, up 91.68%. Net profit has compounded at 76.37% a year since FY22, while revenue has grown 59.53% a year. Operating margin was 20.70% in FY26.
The stock trades at a PE of 13.34 against an industry PE of 45.71, below the sector average, with a return on equity of 26.71%. In the June 2026 quarter, revenue rose 45.98% to Rs 1,407.29 crore and net profit grew 35.55% to Rs 174.70 crore. The share price has gained 219.09% over five years.
High Margin and Fast Revenue Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these high margin and fast revenue growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic | 835 | 172.98 | 19.34% | 15.13% | 22.76% | 46.35% |
| Metropolis | 1,671.43 | 191.18 | 24.15% | 7.62% | 15.69% | 25.83% |
| Paras Defence | 492.56 | 89.45 | 32.20% | 27.65% | 35.87% | 26.46% |
| Genus Power | 4,821.22 | 564.95 | 90.97% | 59.53% | 45.98% | 22.14% |
Check the Univest Screener for live data on these high margin and fast revenue growth stocks
Institutional Holding in Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power
Institutional holding shows who is backing these high margin and fast revenue growth stocks alongside the promoter. The table uses the latest reported quarter for each. Metropolis has the deepest institutional backing, with FII and DII together holding 46.15% as of June 2026. Domestic institutions increased their holding over the past year in Vijaya Diagnostic (from 25.34% to 32.50%), Metropolis (from 32.40% to 35.12%) and Paras Defence (from 1.47% to 4.63%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Vijaya Diagnostic | 52.46% | 10.66% | 32.50% | 4.38% | September 2026 |
| Metropolis | 48.86% | 11.03% | 35.12% | 4.99% | June 2026 |
| Paras Defence | 53.20% | 7.48% | 4.63% | 34.70% | September 2026 |
| Genus Power | 39.34% | 18.72% | 3.05% | 38.89% | June 2026 |
Risks to Weigh in High Margin and Fast Revenue Growth Stocks
Being careful with high margin and fast revenue growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Paras Defence trades at a PE of 113.23 against an industry PE of 48.70, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between High Margin and Fast Revenue Growth Stocks
Picking from high margin and fast revenue growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (45.71 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power live prices.
Conclusion
Among high margin and fast revenue growth stocks, Vijaya Diagnostic stands out for the largest market cap at Rs 15,226 crore, Metropolis for 24.15% revenue growth in FY26, Paras Defence for the biggest five-year price gain at 235.84% and Genus Power for the highest return on equity at 26.71%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high margin and fast revenue growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on High Margin and Fast Revenue Growth Stocks to Watch
Which are the best high margin and fast revenue growth stocks to watch for multibagger potential?
Ans. Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power are the 4 names this list highlights, with market caps of Rs 15,226 crore, Rs 11,603 crore, Rs 10,859 crore and Rs 8,693 crore respectively. Vijaya Diagnostic is notable for the largest market cap at Rs 15,226 crore. Metropolis stands out for 24.15% revenue growth in FY26. Paras Defence offers the biggest five-year price gain at 235.84%. Genus Power brings the highest return on equity at 26.71%. These are watchlist names for high margin and fast revenue growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Genus Power a good stock for long-term investors?
Ans. Genus Power has a return on equity of 26.71%, a PE of 13.34 against an industry PE of 45.71 and a market cap of Rs 8,693 crore. Net profit has compounded at 76.37% a year since FY22, and FY26 revenue rose 90.97% while June 2026 quarter net profit grew 35.55%. Long-term returns in high margin and fast revenue growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Paras Defence become a multibagger from here?
Ans. Paras Defence has already gained 235.84% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high margin and fast revenue growth stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 34.81% a year since FY22, and FY26 revenue rose 32.20%. At a PE of 113.23 against an industry PE of 48.70, valuation should be checked against that growth before investing.
What is the market cap of Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power?
Ans. As of 29 October 2026, Vijaya Diagnostic has a market cap of Rs 15,226 crore, Metropolis has a market cap of Rs 11,603 crore, Paras Defence has a market cap of Rs 10,859 crore and Genus Power has a market cap of Rs 8,693 crore. All of them qualify as smallcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high margin and fast revenue growth stocks.
What are the risks of investing in high margin and fast revenue growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Paras Defence trades at a PE of 113.23 against an industry PE of 48.70, so earnings growth needs to hold up.
Why is Paras Defence trading at a PE of 113.23?
Ans. Paras Defence’s PE of 113.23 compares with an industry PE of 48.70. The market is paying a premium for profit growth of 34.81% a year since FY22, latest-quarter profit growth of 45.34% and FY26 revenue growth of 32.20%, which also means the stock is more sensitive if growth slows. Investors in high margin and fast revenue growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Vijaya Diagnostic, Metropolis, Paras Defence and Genus Power?
Ans. As of the latest reported quarter, FII and DII together hold 43.16% of Vijaya Diagnostic (10.66% and 32.50%), 46.15% of Metropolis (11.03% and 35.12%), 12.11% of Paras Defence (7.48% and 4.63%) and 21.77% of Genus Power (18.72% and 3.05%). Rising institutional holding is a useful signal in high margin and fast revenue growth stocks, though it should be read with earnings trends rather than on its own.
